関連する実験動画
Updated: Sep 10, 2025

11:10
Hyperinsulinemic-euglycemic Clamps in Conscious, Unrestrained Mice
Published on: November 16, 2011
94.7K
コルチコステロイド治療後に発見された内生性低血糖症の希少形態
Adina Simona Dragomir1, Georgiana Cristina Taujan2, Mihai Vlad Dragan1
1C I Parhon National Institute of Endocrinology, Bucharest, Romania.
Endocrinology, diabetes & metabolism case reports
|August 21, 2025
まとめ
このケーススタディは,薬剤誘発インスリン自己免疫症候群 (IAS) を強調し,低血糖症の珍しい原因である. グルココルチコイド薬は 白人の女性でIASを誘発し 食事の変更で成功しました
科学分野:
- 内分泌学
- 内科 医学
- 臨床事例研究
背景:
- インスリン自己免疫症候群 (IAS) は低血糖症の稀な原因であり,特に白人の集団では発生する.
- 薬剤によるIASは極めてまれで,トリガーとしてグルココルチコイド薬に関する文献は限られている.
- IASの正確な診断は,不必要な調査を防止し,適切な治療を導くために不可欠です.
研究 の 目的:
- グルココルチコイド薬によって引き起こされたインスリン自己免疫症候群 (IAS) を報告する.
- 薬物によるIASの診断プロセスと成功管理を図解する.
- 低血糖症の稀な原因を臨床的に考慮する重要性を強調する.
主な方法:
- 52歳の白人の女性の臨床表現 繰り返される低血糖症
- 食事後の低血糖症,インスリン濃度の上昇,および抗インスリン抗体の生化学的確認
- 腰椎椎間板ヘルニアの最近のコルチコステロイド治療に焦点を当てた潜在的なトリガーの評価
主要な成果:
- 食事から4~5時間後に低血糖エピソードが発生し,IASの兆候を示した.
- IASの診断は,高レベルのインスリンと抗インスリン抗体によって確認された.
- 他の自己免疫疾患がない場合,グルココルチコイド薬がIASの潜在的な原因として特定されました.
結論:
- グルココルチコイド誘発型インスリン自己免疫症候群は希少だが,低血糖症の原因である可能性が高い.
- 軽度のIASのエピソードの管理において,食事の変更 (小さい,頻繁な,低炭水化物の食事) が効果的であった.
- 臨床的低血糖症の解消とインスリン濃度の改善は,食事療法の3ヶ月後に観察された.
さらに関連する動画
関連する概念動画
Hypoglycemia and Glucagon
334
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
334
Diabetes Mellitus: Overview and Type I Subtype
3.2K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
3.2K
Diabetes Mellitus: Type 2 and Gestational
2.9K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.9K
Adrenal Gland Disorders
1.8K
Adrenal gland disorders manifest when the production of adrenal hormones deviates from the norm, resulting in either excessive or insufficient concentrations.
Adrenal insufficiency, characterized by insufficient cortisol and aldosterone production, leads to conditions like Addison's disease. This disorder, affecting the adrenal cortex, exhibits symptoms such as skin bronzing, dehydration, low blood pressure, fatigue, and weight loss. Congenital adrenal hyperplasia, a genetic ailment causing...
Adrenal insufficiency, characterized by insufficient cortisol and aldosterone production, leads to conditions like Addison's disease. This disorder, affecting the adrenal cortex, exhibits symptoms such as skin bronzing, dehydration, low blood pressure, fatigue, and weight loss. Congenital adrenal hyperplasia, a genetic ailment causing...
1.8K
Insulin: Dosing Regimen and Adverse Effects
257
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
257
Overview of Carbohydrate Metabolism
1.8K
Carbohydrate metabolism is a fundamental biochemical process that ensures a constant supply of energy to living cells. The most important carbohydrate is glucose, which can be broken down via glycolysis to enter into the Krebs cycle and eventually lead to the production of ATP through oxidative phosphorylation.
Glucose transport into cells is facilitated by a family of transport proteins called GLUT (Glucose Transporters). GLUT4 is the primary glucose transporter for insulin-stimulated glucose...
Glucose transport into cells is facilitated by a family of transport proteins called GLUT (Glucose Transporters). GLUT4 is the primary glucose transporter for insulin-stimulated glucose...
1.8K

